Getting More From Your Buffer Management Strategy

Lonza Biologics, a global leader in biopharmaceutical manufacturing, embarked on an ambitious facility expansion. However, they faced a significant challenge: limited space for buffer preparation and storage. Their solution? Asahi Kasei Bioprocess America's (AKBA) MOTIV™ inline buffer formulation technology.
This case study delves into Lonza's successful implementation of MOTIV™, highlighting the technology's space-saving benefits, increased efficiency, and sustainability gains. Discover how Lonza:
- Overcame space constraints by eliminating the need for large storage tanks and single-use bioprocess containers.
- Reduced resource consumption and waste generation, aligning with their sustainability goals.
- Streamlined buffer preparation, saving time and increasing productivity.
Download the full case study to gain insights into Lonza's journey with AKBA's MOTIV™ technology and discover the impact it can have on your buffer management strategy.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.